Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

SARS-CoV-2 Spike Protein (B.1.525 - eta) (rho-1D4 tag)

Origine: SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Eta Hôte: HEK-293 Cells Recombinant >98% as determined by SDS-PAGE ELISA, LBA
N° du produit ABIN6972924
  • Highlights
    • Recombinant trimeric S protein of the SARS-CoV-2 variant of interest B.1.525.
    • Contains Q52R, del 69-70, del 144, E484K, F888L, and Q677H mutations characteristic for the SARS-CoV-2 eta variant (B.1.525).
    Antigène Voir toutes SARS-CoV-2 Spike Protéines
    SARS-CoV-2 Spike
    Type de proteíne
    Recombinant
    Attributs du protein
    B.1.525 - eta
    Origine
    • 223
    • 37
    • 9
    • 8
    • 7
    • 6
    • 6
    • 5
    • 4
    • 4
    • 3
    • 2
    • 1
    SARS Coronavirus-2 (SARS-CoV-2), SARS CoV-2 Eta
    Source
    • 198
    • 7
    • 7
    • 3
    • 3
    • 3
    • 2
    • 1
    • 1
    • 1
    • 1
    HEK-293 Cells
    Purification/Conjugué
    Cette SARS-CoV-2 Spike protéine est marqué à la rho-1D4 tag.
    Application
    ELISA, Ligand Binding Assay (LBA)
    Fonction
    SARS CoV-2 full-length Spike B.1.525 Mutation
    Séquence
    MFVFLVLLPL VSSQCVNLTT RTQLPPAYTN SFTRGVYYPD KVFRSSVLHS TRDLFLPFFS NVTWFHAISG TNGTKRFDNP VLPFNDGVYF ASTEKSNIIR GWIFGTTLDS KTQSLLIVNN ATNVVIKVCE FQFCNDPFLG VYHKNNKSWM ESEFRVYSSA NNCTFEYVSQ PFLMDLEGKQ GNFKNLREFV FKNIDGYFKI YSKHTPINLV RDLPQGFSAL EPLVDLPIGI NITRFQTLLA LHRSYLTPGD SSSGWTAGAA AYYVGYLQPR TFLLKYNENG TITDAVDCAL DPLSETKCTL KSFTVEKGIY QTSNFRVQPT ESIVRFPNIT NLCPFGEVFN ATRFASVYAW NRKRISNCVA DYSVLYNSAS FSTFKCYGVS PTKLNDLCFT NVYADSFVIR GDEVRQIAPG QTGKIADYNY KLPDDFTGCV IAWNSNNLDS KVGGNYNYLY RLFRKSNLKP FERDISTEIY QAGSTPCNGV KGFNCYFPLQ SYGFQPTNGV GYQPYRVVVL SFELLHAPAT VCGPKKSTNL VKNKCVNFNF NGLTGTGVLT ESNKKFLPFQ QFGRDIADTT DAVRDPQTLE ILDITPCSFG GVSVITPGTN TSNQVAVLYQ DVNCTEVPVA IHADQLTPTW RVYSTGSNVF QTRAGCLIGA EHVNNSYECD IPIGAGICAS YQTHTNSPGS ASSVASQSII AYTMSLGAEN SVAYSNNSIA IPTNFTISVT TEILPVSMTK TSVDCTMYIC GDSTECSNLL LQYGSFCTQL NRALTGIAVE QDKNTQEVFA QVKQIYKTPP IKDFGGFNFS QILPDPSKPS KRSFIEDLLF NKVTLADAGF IKQYGDCLGD IAARDLICAQ KFNGLTVLPP LLTDEMIAQY TSALLAGTIT SGWTLGAGAA LQIPFAMQMA YRFNGIGVTQ NVLYENQKLI ANQFNSAIGK IQDSLSSTAS ALGKLQDVVN QNAQALNTLV KQLSSNFGAI SSVLNDILSR LDPPEAEVQI DRLITGRLQS LQTYVTQQLI RAAEIRASAN LAATKMSECV LGQSKRVDFC GKGYHLMSFP QSAPHGVVFL HVTYVPAQEK NFTTAPAICH DGKAHFPREG VFVSNGTHWF VTQRNFYEPQ IITTDNTFVS GNCDVVIGIV NNTVYDPLQP ELDSFKEELD KYFKNHTSPD VDLGDISGIN ASVVNIQKEI DRLNEVAKNL NESLIDLQEL GKYEQYIKWP WYIWLGFIAG LIAIVMVTIM LCCMTSCCSC LKGCCSCGSC CKFDEDDSEP VLKGVKLHYT GSSGTETSQV APA
    Specificité
    Mutation that differ from "original" SPIKE protein: Q52R, del 69-70, del 144, E484K, F888L, Q677H
    Attributs du produit
    "SARS CoV-2 full-length Spike B.1.525 Mutation"
    All viruses undergo fast mutations and adept quickly to the countermeasures that the immune systems creates against them. SARS-CoV-2 of the COVID-19 pandemic is no exception here. During the pandemic multiple mutant strains arose. To help the science combat these mutants we offer these mutant SPIKE proteins.
    Purification
    Affinity Chromatography
    Pureté
    >98% as determined by SDS-PAGE
    Top Product
    Discover our top product SARS-CoV-2 Spike Protéine
  • Indications d'application
    Optimal working dilution should be determined by the investigator.
    Commentaires

    Further modifications:
    - furin cleavage site "682-RRAR|SV-687" mutated to "682-GSAG|PP-687"
    - C-terminal Rho1D4 tag fused with spacer "GSSG" to protein sequence

    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    20 mM Hepes pH 7.5, 150 mM NaCl, 0.001 % LMNG
    Stock
    -80 °C
    Stockage commentaire
    Store at -80°C. Avoid freeze-thaw cycles
  • Antigène
    SARS-CoV-2 Spike
    Autre désignation
    SARS2 Spike glycoprotein (SARS-CoV-2 Spike Produits)
    Classe de substances
    Viral Protein
    Poids moléculaire
    141683.90 Da
    UniProt
    P0DTC2
Vous êtes ici:
Support technique